Comparison of Application Effects Between Long- and Standard Short- Peripheral Venous Catheters

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorShenzhen Third People's Hospital

About this trial

Short PIVC (intravenous indentation needle) accounts for more than 50% of clinical infusion tools, but long PIVC is rarely used and studied in China. This study aims to explore the application characteristics and application effects of long PIVC in China. It provides reference for the correct selection of infusion tools, and promotes the clinical application and promotion of new intravenous therapy tools.

The study nurse will work with the responsible physician to assess the eligibility for enrollment and sign the informed consent. Were randomly assigned to the control group (to receive a new 24G/22G (0.7mm\*19mm/0.9mm\*25mm) short PIVC (closed needle protected venous catheter system) puncture) or the intervention group (to insert a new 3F (8cm) or 4F(10cm) long PIVC) for daily routine maintenance until catheter removal, General demographic data, laboratory-related data, catheter-related data, catheter-related complications (unplanned extubation, phlebitis, catheter blockage, catheter-related thrombosis, catheter-related bloodstream infection, exudation, etc.) and patient satisfaction were collected.

Eligibility criteria

Qualifiers

A male or female aged 18 years or older who is able and willing to give written informed consent;

Identification of the patient's medical diagnosis based on the competent physician and the study nurse at any time during the hospital stay, and judgment that the duration of peripheral intravenous infusion therapy needs to exceed 4 days;

Subjects with good compliance and can cooperate with catheter maintenance and observation.

Disqualifiers

Patients who are delirious and unable to cooperate;

Patients requiring central venous access;

Patients suffering from connective tissue diseases or blood diseases;

Patients allergic to catheters or dressings;

Trial design

Treatments tested in this trial

  • Long peripheral venous catheter
  • Control group (Short peripheral venous catheter)

Treatment groups

250 Participants
are divided into 2 treatment groups